Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objective: This study aimed to evaluate the effect of inter-pregnancy interval (IPI) on the gestational diabetes (GDM) recurrence rate in subsequent pregnancies following an initial pregnancy complicated by GDM. Study Design: A multicenter retrospective cohort study was conducted. The study included women diagnosed with GDM during their index pregnancy who subsequently delivered between 26 and 42 weeks of gestation from 2005 to 2021. The study population was categorized into 8 groups according to their IPIs: up to 3 months, 3-5 months, 6-11 months, 12-17 months, 18-23 months, 24-35 months, 36-47 months, and over 48 months. We examined the recurrence rate of GDM in the different groups compared to the 18-23 months group that was defined as the reference. Statistical analyses included univariate analyses and multiple logistic regression. Results: Out of 3,532 women that were included in the study, 1776 (50.3%) experienced GDM recurrence in subsequent pregnancy. The recurrence rate was 44.6% for women IPI <6 months, 42.6% for women IPI of 6-11 months, 48.0% for women IPI of 12-17 months, 49.7% for women IPI of 18-23 months, 58.0% for women IPI of 24-47 months and 62.6% for women IPI above 48 months. Multivariable logistic regression revealed that IPIs of 24-47 months and over 48 months were significantly associated with higher recurrence rates as compared to the 18-23 months reference group (adjusted odds ratio [aOR], 95% confidence interval [CI] 1.66 [1.04-2.64] and 3.15 [1.07-9.29], respectively). This analysis also revealed other independent risk factors for GDM recurrence including medication-controlled GDM in the index pregnancy, obesity, maternal age, parity, and gravidity. Conclusion: Longer IPIs (over 24 months) are associated with an increased risk of GDM recurrence in subsequent pregnancies. Clinicians should consider IPI when managing postpartum care and planning future pregnancies for women with a history of GDM.
Objective: This study aimed to evaluate the effect of inter-pregnancy interval (IPI) on the gestational diabetes (GDM) recurrence rate in subsequent pregnancies following an initial pregnancy complicated by GDM. Study Design: A multicenter retrospective cohort study was conducted. The study included women diagnosed with GDM during their index pregnancy who subsequently delivered between 26 and 42 weeks of gestation from 2005 to 2021. The study population was categorized into 8 groups according to their IPIs: up to 3 months, 3-5 months, 6-11 months, 12-17 months, 18-23 months, 24-35 months, 36-47 months, and over 48 months. We examined the recurrence rate of GDM in the different groups compared to the 18-23 months group that was defined as the reference. Statistical analyses included univariate analyses and multiple logistic regression. Results: Out of 3,532 women that were included in the study, 1776 (50.3%) experienced GDM recurrence in subsequent pregnancy. The recurrence rate was 44.6% for women IPI <6 months, 42.6% for women IPI of 6-11 months, 48.0% for women IPI of 12-17 months, 49.7% for women IPI of 18-23 months, 58.0% for women IPI of 24-47 months and 62.6% for women IPI above 48 months. Multivariable logistic regression revealed that IPIs of 24-47 months and over 48 months were significantly associated with higher recurrence rates as compared to the 18-23 months reference group (adjusted odds ratio [aOR], 95% confidence interval [CI] 1.66 [1.04-2.64] and 3.15 [1.07-9.29], respectively). This analysis also revealed other independent risk factors for GDM recurrence including medication-controlled GDM in the index pregnancy, obesity, maternal age, parity, and gravidity. Conclusion: Longer IPIs (over 24 months) are associated with an increased risk of GDM recurrence in subsequent pregnancies. Clinicians should consider IPI when managing postpartum care and planning future pregnancies for women with a history of GDM.
BackgroundCholesterol is essential for pregnant women to maintain maternal health and fetal support development. This study aimed to assess the cholesterol intake of women with gestational diabetes mellitus (GDM) during the second and third trimesters of pregnancy and to explore its effects on blood glucose and pregnancy outcomes.MethodsThis prospective cohort study collected dietary data using a food frequency questionnaire (FFQ) administered during the 24–30 gestational weeks (first survey) and the 34–42 gestational weeks (second survey). Blood glucose parameters and pregnancy outcomes were obtained from electronic medical records. Participants were divided into two groups according to the median cholesterol intake: low and high cholesterol intake groups.ResultsGDM women generally consumed high levels of cholesterol during pregnancy, with intake increasing in the third trimester compared to the second trimester. Compared to women with high cholesterol intake, GDM women with low cholesterol intake had a higher risk of abnormal hemoglobin A1C (HbA1C) during the second trimester [OR 26.014 (95% CI 2.616–258.727)] and the third trimester [OR 2.773 (95% CI 1.028–7.482)], as well as abnormal fasting blood glucose during the third trimester [OR 2.907 (95% CI 1.011–8.360)]. Furthermore, in the second trimester, GDM women with high cholesterol intake had higher risks of macrosomia [OR 23.195 (95% CI 2.650–203.024)] and large for gestational age (LGA) [OR 3.253 (95% CI 1.062–9.965)] but lower risks of small for gestational age (SGA) [OR 0.271 (95% CI 0.074–0.986)] compared to those with low cholesterol intake. However, in the third trimester, GDM women with high cholesterol intake had lower risks of macrosomia [OR 0.023 (95% CI 0.001–0.436)] and LGA [OR 0.199 (95% CI 0.042–0.949)].ConclusionCholesterol intake among GDM women during pregnancy was associated with blood glucose control and significantly influenced the risks of macrosomia, LGA, and SGA. However, LGA and SGA were also influenced by pre-pregnancy BMI, indicating cholesterol intake was one of multiple contributing factors. Limiting cholesterol intake may help GDM women better manage blood glucose levels and mitigate adverse pregnancy outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.